labetalol and amlodipine

labetalol has been researched along with amlodipine in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.00)	18.2507
2000's	9 (45.00)	29.6817
2010's	8 (40.00)	24.3611
2020's	2 (10.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Lund-Johansen, P; Omvik, P	1
Castelino, FV; Collier, D; Wasfy, JH	1
Bendersky, M; Ferdinand, KC; Forcada, P; Grassi, D; Kotliar, C; O'Flaherty, M; Pellizzari, M; Rodriguez, P; Turri, D	1
Chernin, G; Francis, M; Heeringa, SF; Soliman, NA	1
Kauntia, R; Pandit, VR; Prabhu, MM; Seshadri, S; Valsalan, R	1
Campbell, P; Jain, K; Schuchard, G; Singh, KP; White, WB	1
Abrams, RI; Baxi, PV; Herring, MJ; Korbet, SM; Lichtenstein, SJ	1
Lodebo, BT; Pearlman, B	1
Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C	1

Reviews

1 review(s) available for labetalol and amlodipine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for labetalol and amlodipine

Article	Year
Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. Journal of clinical hypertension (Greenwich, Conn.), 2008, Volume: 10, Issue:9 Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Emergencies; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hypertension; Labetalol; Male; Middle Aged; Perindopril; Rest; Retrospective Studies; Treatment Outcome	2008

Article

Year

Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles.

Journal of clinical hypertension (Greenwich, Conn.), 2008, Volume: 10, Issue:9

Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Emergencies; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hypertension; Labetalol; Male; Middle Aged; Perindopril; Rest; Retrospective Studies; Treatment Outcome

2008

Other Studies

18 other study(ies) available for labetalol and amlodipine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin. Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:2 Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines	1993
A 36-year-old man with paresthesias and a headache. Arthritis and rheumatism, 2008, Sep-15, Volume: 59, Issue:9 Topics: Adult; Amlodipine; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Guanine; Headache; Hepatitis B; Humans; Labetalol; Lymphoma, Non-Hodgkin; Male; Paresthesia; Prednisone; Substance Abuse, Intravenous; Sural Nerve; Treatment Outcome; Vasculitis	2008
Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade? Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:5 Topics: Albumins; Amlodipine; Angiotensins; Antihypertensive Agents; Captopril; Drug Resistance; Drug Therapy, Combination; Furosemide; Glomerulosclerosis, Focal Segmental; Humans; Infant; Labetalol; Male; Nephrotic Syndrome; Prednisolone; Remission Induction; Renin-Angiotensin System	2009
Late postpartum preeclampsia with posterior reversible encephalopathy syndrome. Indian journal of medical sciences, 2009, Volume: 63, Issue:11 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Blindness, Cortical; Eclampsia; Female; Humans; Labetalol; Posterior Leukoencephalopathy Syndrome; Postpartum Period; Pregnancy; Time Factors	2009
Severe circadian hypertension in a young man. The American journal of medicine, 2011, Volume: 124, Issue:10 Topics: Amlodipine; Angioplasty, Balloon; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Humans; Hypertension; Labetalol; Male; Radiography; Renal Artery; Renal Artery Obstruction; Young Adult	2011
Without Warning: Scleroderma Renal Crisis. The American journal of medicine, 2019, Volume: 132, Issue:2 Topics: Acute Kidney Injury; Amlodipine; Antihypertensive Agents; Humans; Hypertension; Labetalol; Lisinopril; Male; Nicardipine; Scleroderma, Limited	2019
Renin secreting tumour: a rare cause of secondary hypertension. Lancet (London, England), 2021, 09-18, Volume: 398, Issue:10305 Topics: Adult; Amlodipine; Antihypertensive Agents; Female; Humans; Hypertension; Kidney Neoplasms; Labetalol; Nephrectomy; Renin; Seizures; Tomography, X-Ray Computed; Young Adult	2021
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy. Drug testing and analysis, 2022, Volume: 14, Issue:10 Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry	2022